Waverley Pharma, Inc. (WAVE.V)
0.01
0.00 (0.00%)
CAD |
TSXV |
Oct 23, 16:00
Waverley Pharma Shareholders Equity (Quarterly) : -2.859M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.859M |
| March 31, 2026 | -2.725M |
| December 31, 2025 | -2.571M |
| September 30, 2025 | -2.362M |
| June 30, 2025 | -2.138M |
| March 31, 2025 | -2.069M |
| December 31, 2024 | -2.032M |
| September 30, 2024 | -2.017M |
| June 30, 2024 | -1.743M |
| March 31, 2024 | -1.400M |
| December 31, 2023 | -1.137M |
| September 30, 2023 | 0.1923M |
| June 30, 2023 | 0.5023M |
| March 31, 2023 | 0.7472M |
| December 31, 2022 | 1.091M |
| September 30, 2022 | 1.416M |
| June 30, 2022 | 1.562M |
| March 31, 2022 | 1.595M |
| December 31, 2021 | 1.789M |
| Date | Value |
|---|---|
| September 30, 2021 | 1.518M |
| June 30, 2021 | 1.692M |
| March 31, 2021 | 1.879M |
| December 31, 2020 | 2.043M |
| September 30, 2020 | 2.448M |
| June 30, 2020 | 2.478M |
| March 31, 2020 | 2.783M |
| December 31, 2019 | 2.845M |
| September 30, 2019 | 3.160M |
| June 30, 2019 | 3.596M |
| March 31, 2019 | 3.816M |
| December 31, 2018 | 3.972M |
| September 30, 2018 | 4.114M |
| June 30, 2018 | 4.270M |
| March 31, 2018 | 4.794M |
| December 31, 2017 | 5.057M |
| September 30, 2017 | 0.2377M |
| June 30, 2017 | 0.3672M |
| March 31, 2017 | 0.0888M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Kane Biotech, Inc. | -0.9939M |
| Quest PharmaTech, Inc. | 26.43M |
| BriaCell Therapeutics Corp. | 32.75M |
| Vaxil Bio Ltd. | 1.194M |
| Goldcoast Resource Corp. | 0.594M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.106M |
| Total Liabilities (Quarterly) | 3.965M |
| Debt to Equity Ratio | -1.261 |
| Current Ratio | 0.092 |
| Net Debt Paydown Yield | -7.57% |